Avenda Health

Avenda Health is a private, commercial-stage digital health company focused on transforming prostate cancer care through its artificial intelligence platform, Unfold AI. The FDA-cleared software analyzes standard MRI, biopsy, and pathology data to generate a precise 3D map of cancer location and extent, aiding physicians in surgical planning, focal therapy targeting, and active surveillance. With clinical studies demonstrating its ability to significantly improve cancer-free margins compared to MRI alone, Avenda is addressing a critical need for personalized treatment in a large and growing market. The company is in early revenue generation, navigating insurance reimbursement while expanding its provider network across the United States.

Unfold AI: An FDA-cleared AI software platform that analyzes standard MRI, biopsy, and pathology data to generate a patient-specific 3D Cancer Estimation Map (heatmap) visualizing the location and extent of prostate cancer for treatment planning.

Avenda competes in the AI-powered medical imaging segment for oncology. Direct competitors may include other startups developing AI for prostate MRI analysis (e.g., for detection rather than 3D mapping). Indirect competition comes from improvements in MRI technology itself and traditional biopsy-guided planning. Avenda's FDA clearance and published clinical validation for treatment planning provide a competitive moat.